|本期目录/Table of Contents|

[1]叶福林,张玉景,黄 兵,等.农村偏远地区心脏瓣膜置换术后的抗凝治疗[J].医学研究与战创伤救治(原医学研究生学报),2010,12(03):215-217.
 YE Fu-lin,ZHANG Yu-jing,HUANG Bing,et al.The anticoagulant therapy for the patients with mechanical heart valve prostheses from remote village[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(03):215-217.
点击复制

农村偏远地区心脏瓣膜置换术后的抗凝治疗()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第12卷
期数:
2010年03期
页码:
215-217
栏目:
出版日期:
2010-05-20

文章信息/Info

Title:
The anticoagulant therapy for the patients with mechanical heart valve prostheses from remote village
文章编号:
1672-271X(2010)03-0215-03
作者:
叶福林1张玉景1黄 兵1朱建福1房毓庆1王泽新1陆方林2
1. 221004 江苏徐州,解放军97医院心胸外科;2. 200433 上海,第二军医大学附属长海医院心胸外科
Author(s):
YE Fu-lin1 ZHANG Yu-jing1 HUANG Bing1 ZHU Jian-fu1 FANG Yu-qing1 WANG Ze-xin1 LU Fang-lin2
1. Department of Thoracic and Cardiac Surgery, 97 Hospital of PLA, Xuzhou, Jiangsu 221004, China; 2. Department of Thoracic and Cardiac Surgery, Changhai Hospital affiliated to the Second Military Medical University, Shanghai 200433, China
关键词:
心脏瓣膜疾病心脏瓣膜人工抗凝药随访研究国际标准化比
Keywords:
heart valve diseases heart valve prosthesesartificial anticoagulants follow-up studies INR
分类号:
R654.2
DOI:
-
文献标志码:
A
摘要:
目的 观察农村偏远地区心脏瓣膜置换术后的抗凝治疗,为农村偏远地区换瓣患者提供一种简单可行的抗凝方法。方法 近3年30名农村偏远地区换瓣患者(观察组)与31名城镇换瓣患者(对照组)术后抗凝,口服华法林片,剂量根据凝血酶原时间(PT)、国际标准化比(INR)调整,观察组的抗凝监测间隔时间较对照组延长,抗凝强度一样。同时进行抗凝的宣教。结果 61例患者中测得INR共742次,其中观察组329次,对照组413次,INR控制在1.5~2.0的596次。住院期间两组患者无严重出血及栓塞并发症,出院后观察组1例1月后出现感染性心内膜炎死亡,2例牙龈出血,4例月经过多。对照组2例牙龈出血,3例月经过多。 结论 采用INR 1.5~2.0抗凝治疗强度是安全可靠的,通过加强抗凝的宣教,适当延长检测间隔时间的方法并不影响换瓣术后中短期抗凝效果。
Abstract:
Objective To observe the effect of oral anticoagulant therapy on patients with mechanical heart valve prostheses and to provide a simple and feasible anticoagulant therapy for patients from remote village. Methods 30 patients from remote village (experimental group) and 31 patients from city (control group) underwent mechanical heart valve replacement in recent 3 years were involved in the study. The dose of warfarin tablet was adjusted according to the prothrombin time (PT) and international normalized ratio (INR) when warfarin taken for anticoagulation. The interval time of anticoagulation in experimental group was properly prolonged comparing with control group. Knowledge of anticoagulation was educated to patients. Results A total of 742 blood specimens from 61 patients of INR were tested, in which 413 cases in control group and 329 in experimental group. 596 cases of INR were controlled within 1.5 ~ 2.0. There was no severe complication of hemorrhage and embolism between the two groups in hospital. One case died of infective endocarditis a month later post-discharge, 2 cases showed gingival bleeding and 4 with hypermenorrhea in experimental group. 2 cases showed gingival bleeding and 3 with hypermenorrhea in control group. Conclusion It’s safe and reliable to anticoagulate according to the uniform standard intensity within the range of INR of 1.5~2.0. It could not affect the short and mid-half term anticoagulant effect when the interval time of anticoagulant monitoring properly prolonged with the help of anticoagulant education.

参考文献/References:

[1] Sidhu P, O’Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients[J]. Ann Thorac Surg, 2001, 72 (5): 1523-1527.
[2] Kontozis L, Skudicky D, Hopley MJ, et al. Long-term follow-up of St.Jude medical prosthesis in a young rheumatic population using low-level warfarin anticoagulation: an analysis of the temporal distribution of causes of death [J]. Am J Cardiol, 1998, 81(6): 736-739.
[3] 董 力,石应康,邓承祺,等. 应用国际标准比值监测心脏机械瓣膜替换术后抗凝治疗[J]. 中华胸心血管外科杂志,1999,15 (3): 167-169.
[4] Zhou XM, zhuang W, Hu JG, et al. Low-dose anticoagulation in Chinese patients with mechanical heart valves[J]. Asian Cardiovasc Thorac Ann, 2005, 13(4): 341-344.
[5] Torn M, Cannegiter SC, Bollen WL, et al. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients[J]. Arch Intern Med, 2009,169 (13): 1203-1209.
[6] 刘 岩,孟 旭,陈宝田,等. 人工机械瓣膜低强度抗凝治疗的标准[J]. 中华胸心血管外科杂志,2001,17 (5): 263-265.
[7] Acar J, Lung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves[J]. Circulation, 1996,94 (9): 2107-2112.
[8] Hirsh J. Oral anticoagulation drugs [J]. N Engl J Med, 1991, 324(26): 1865-1875.
[9] 董 力,石应康,赵雍凡,等. 心脏机械瓣替换术后126例抗凝治疗随访[J]. 中华胸心血管外科杂志,1996,12 (3): 149-151.

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2010-05-20